کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1993143 1064618 2015 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Efficacy of integrative medicine in deficiency of both qi and yin in the rat model of type 2 diabetes
ترجمه فارسی عنوان
اثربخشی داروهای یکپارچه در کمبود هر دو qi و yin در مدل رت دارای دیابت نوع 2
کلمات کلیدی
دیابت نوع 2؛ کمبود هر دو qi و yin ؛ پزشکی انتگرال؛ فرمول گیاهی چینی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی زیست شیمی
چکیده انگلیسی

ObjectiveTo establish a rat model of type 2 diabetes (T2DM) manifesting the Chinese medicine syndrome pattern of both qi and yin deficiency for evaluating the efficacy of a Chinese herbal formula (CHF), integrative medicine (IM), and pioglitazone (PIO) on T2DM indicators in the animal model.MethodsThe rat model was induced by a high-fat diet (HFD) and streptozotocin (STZ, 30 mg/kg). CHF (3.4 g/kg), PIO (2.7 mg/kg), and IM (3.4 g CHF + 2.7 mg PIO) were administered to rats once daily for 14 days. Related laboratory parameters were observed.ResultsDiabetic rats showed unsmooth fur, alopecia, reduced activity, huddling, somnolence, depression, pale or reddened tongue, damp/dark red tail, and high levels of water and food intake, urine volume, and stool weight, but weakened grip strength. Low levels of serum SOD, Na+-K+-ATPase, cAMP/cGMP, and a high level of iNOS were observed. Hyperglycemia, hyperinsulinemia, insulin resistance, high levels of serum glucagon/IDE and pancreatic amylin, and low serum and pancreatic SS levels were evident as well.ConclusionsA rat model of T2DM with both qi and yin deficiency was successfully replicated. CHF appeared to be more efficacious than IM and PIO in the rat model of qi and yin deficiency pattern of T2DM, though IM and PIO were each found to have their merits and drawbacks in attenuating T2DM indicators in the rat model.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Traditional Chinese Medical Sciences - Volume 2, Issue 4, October 2015, Pages 258–263
نویسندگان
, , , , , , , , ,